OncoLens
PrivateLast Round
Series B
Oct 24, 2024
Est. Valuation
$55M
Total Funding Raised
$27.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoLens is a healthtech company that provides an AI-driven, oncology-focused digital health platform that enhances cancer care through analytics, multidisciplinary collaboration tools, and clinical trial matching.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Workflow Automation, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoLens Comparables
Compare OncoLens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galen Health | 79% | |
| Health Catalyst | 77% | |
| Triomics | 77% |
OncoLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 24, 2024 | ||||
| Corporate Funding | Jul 13, 2023 | ||||
| Series A | Jan 14, 2021 | ||||
| Seed | Jan 7, 2020 | ||||
| Seed | Mar 26, 2019 |
Key People
Founding team and executive leadership
OncoLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIP Capital | Series A, Seed, Series B |
| SeedtoB Capital | Series A, Series B |
| Cross Border Impact Ventures | Corporate Funding, Series B |
| Atlanta Technology Angels | Seed |
| Martin Ventures | Series A, Series B |
| Panoramic Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 71% MoM, reaching 6.7K.
- May 19, 2025
Dr. Walter "Wally" Curran joins the Advisory Board.
OncoLens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoLens's valuation, stock price, and market status.
Is OncoLens a public or private company?
OncoLens is a private company.
What is the current stock price of OncoLens?
OncoLens is a private company with no public stock price. No recent secondary market data is available.
How much is OncoLens worth (valuation)?
Valuation information for OncoLens is not publicly available.
Can I buy OncoLens stock?
OncoLens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoLens's last funding round?
OncoLens's most recent funding round was Series B on October 24, 2024.
Who are the main investors in OncoLens?
Key investors in OncoLens include BIP Capital, Cross Border Impact Ventures, Atlanta Technology Angels.
Will OncoLens IPO soon?
No public IPO plans have been announced for OncoLens.
How can I track OncoLens secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoLens's secondary market activity and sign up for updates.